《新股表现》辉煌明天(01351.HK)暗盘高开7.3%报1.18元
根据辉立交易平台显示,明天挂牌的辉煌明天(01351.HK)暗盘高开7.3%报1.18元,曾倒跌低见1元获承接,现造1.4元,较上市价1.1元,高27%,成交492万股。
辉煌明天是内地一间移动广告公司,主要为客户提供一站式定制广告服务。是次来港上市共发售1.25亿股,并已引入2名基石投资者合共认购3,517.4万股;其中10%公开发售获逾30倍超购,已启动回拨机制占比增至30%,认购一手中签比率45%;股份以招股范围(1-1.1元)上限定价,料集资净额约8,600万元,主要用作扩展集团中介服务、扩展营销和设计团队、以及提升信息技术和数据管理平台系统等。上市独家保荐人大有融资。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.